New Gene-Editing Strategy Could Help Development of Treatments for Rare Diseases

Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for many diseases.David R. Liu, a biologist at the Broad Institute and Harvard, is the lead author of a new study of a gene-editing strategy that could be standardized for multiple people with rare diseases.